ABCB1 C3435T Genetic Polymorphism on Population Pharmacokinetics of Methotrexate After Hematopoietic Stem Cell Transplantation in Korean Patients: A Prospective Analysis-Reference-Cited by-同舟云学术

ABCB1 C3435T Genetic Polymorphism on Population Pharmacokinetics of Methotrexate After Hematopoietic Stem Cell Transplantation in Korean Patients: A Prospective Analysis

Published:2012-08 Issue:8 Volume:34 Page:1816-1826
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Kim In-Wha,Yun Hwi-yeol,Choi Boyoon,Han Nayoung,Park Seon-Yang,Lee Eun Sook,Oh Jung Mi

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference56 articles.

1. Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy;Aschan;Bone Marrow Transplant,1991

2. Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?;Ringden;Blood,1993

3. Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease?;Storb;J Am Soc Blood Marrow Transplant,2010

4. Graft-versus-host disease;Ferrara;N Engl J Med,1991

5. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective;Tomblyn;J Am Soc Blood Marrow Transplant,2009

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. External Evaluation of Population Pharmacokinetic Models for High‐Dose Methotrexate in Adult Patients with Hematological Tumors;The Journal of Clinical Pharmacology;2024-01-11

2. Factors influencing methotrexate pharmacokinetics highlight the need for individualized dose adjustment: a systematic review;European Journal of Clinical Pharmacology;2023-11-07

3. Population Pharmacokinetic Model of Methotrexate in Brazilian Pediatric Patients with Acute Lymphoblastic Leukemia;Pharmaceutical Research;2023-06-08

4. Evaluation and Application of Population Pharmacokinetic Models for Identifying Delayed Methotrexate Elimination in Patients With Primary Central Nervous System Lymphoma;Frontiers in Pharmacology;2022-03-09

5. A Systematic Review of Population Pharmacokinetic Models of Methotrexate;European Journal of Drug Metabolism and Pharmacokinetics;2022-01-05